PLAMECA Celebrates Its 40th Anniversary
The Health and Wellness Company Has Spent Four Decades Serving The Spanish Geography and
The global nutraceutical market was valued at
"In this industry, it matters when a brand has been around the block a few times," says Óscar Fernández. PLAMECA's managing director adds that when a nutraceutical company survives the test of time, it shows that they are offering real value to their customers. They have a track record that demonstrates their ability to produce clean, effective supplements that generate results and keep consumers coming back.
"This year, we're celebrating our 40th anniversary," Fernández explains. "That is a big deal for us. It reminds us that we are genuinely impacting the lives of our customers. It makes it easier to invest in bigger, better things moving forward."
Fernández's reference to "bigger, better things" isn't hyperbole or wishful thinking. As already mentioned, the PLAMECA team is actively using the success of the past to invest millions of dollars in the future of health and wellness. As PLAMECA continues to expand its offerings and global distribution footprint, Americans can count on having the brand's products available for the foreseeable future as they look for consistent, effective solutions to their health and wellness needs.
About Plameca
PLAMECA is a phytotherapy company founded in 1984 with the initial intention of providing medicinal herbs and plants — which it did for 1,500 retailers across the Spanish geography. In 1994, PLAMECA expanded to manufacture its own food supplements, creating a range of products using herbal extracts, vitamins, and minerals. Currently, PLAMECA products are manufactured in modern facilities using up-to-date scientific methods and are sold in 33 countries. As the company celebrates its 40th anniversary this year, it has also invested
Juan M Desvalls
[email protected]
Tel. + 34 677518038
View original content:https://www.prnewswire.com/news-releases/plameca-celebrates-its-40th-anniversary-302081179.html
SOURCE Plameca
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hexagon Agility receives significant order from Certarus for Mobile Pipeline modules to service data center demand
- TIENS VMOMENT Wins Wprost "Business Innovation" Award in Poland
- Ascletis Submits Two IND Applications to the U.S. FDA for the Treatment of Obesity: ASC36 Once-Monthly Injection, a Peptide Amylin Receptor Agonist, and ASC36_35 FDC Once-Monthly Injection, a Co-Formu
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share